ARCHIVES

NCI Shakeup Possibilities Grow; Marc Lippman To Head Lombardi Center; DCT Could Lose CTEP

This article is from The Cancer Letter archive.

Vol. 14 No. 11 | March 11, 1988

Download PDF Visit The Full Archive

Related Articles

NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma.

December 1, 2000

NCAB Criticizes Coverage’ Of NCI Screening Statement

March 4, 1994

Reviewers Report Progress In New Drug Prescreen System Development, Commend DTP

December 15, 1989

Healy Saw Scripps Issue as Way To Revisit Conflict Of Interest

March 19, 1993

Scientists Falsified Research, ORI Says

July 5, 1996

In Brief: HHS Names Deputy HCFA Administrator; M.D. Anderson’s Error-Free Record Honored

July 4, 1997